t was stated that Rh antigens are so sparsely scattered in the red cell surface that IgG molecules bound to the Rh antigens are too far apart to fix C1q.Therefore, complement-mediated hemolysis cannot be invoked to explain hemolytic disease of the newborn. By what mechanism are the red cells destroyed?

Human Anatomy & Physiology (11th Edition)
11th Edition
ISBN:9780134580999
Author:Elaine N. Marieb, Katja N. Hoehn
Publisher:Elaine N. Marieb, Katja N. Hoehn
Chapter1: The Human Body: An Orientation
Section: Chapter Questions
Problem 1RQ: The correct sequence of levels forming the structural hierarchy is A. (a) organ, organ system,...
icon
Related questions
Question

It was stated that Rh antigens are so sparsely scattered in the red cell surface that IgG molecules bound to the Rh antigens are too far apart to fix C1q.Therefore, complement-mediated hemolysis cannot be invoked to explain hemolytic disease of the newborn. By what mechanism are the red cells destroyed?

248
Case 44: Hemolytic Disease of the Newborn
Fig. 44.1 Hemagglutination is used
to type blood and match compatible
donors and recipients for blood
transfusion. Common gut bacteria bear
antigens that are similar or identical to
blood group antigens, and these stimulate
the formation of antibodies against
these antigens in individuals who do not
bear the corresponding antigen on their
own red blood cells (left column); thus,
type O individuals, who lack A and B
antigens, have both anti-A and anti-B
antibodies, whereas type AB individuals
have neither. The pattern of agglutination
of the red blood cells of a transfusion
donor or recipient with anti-A and anti-B
antibodies reveals the individual's ABO
blood group. Before transfusion, the
serum of the recipient is also tested for
antibodies that agglutinate the red blood
cells of the donor, and vice versa, a
procedure called a cross-match, which
may detect potentially harmful antibodies
against other blood groups that are not
part of the ABO system.
30.5 weeks: hematocrit up to
16.3% Further transfusion
requested.
Serum from
individuals of type
Anti-A and anti-B
antibodies
Anti-B antibodies
B
Anti-A antibodies
AB
No antibodies
against A or B
R-GlcNAc-Gal
Fue
no agglutination
no agglutination
no agglutination
no agglutination
Red blood cells from individuals of type
Express the carbohydrate structures
R-GlcNAc-Gal-GalNAc R-GlcNAc-Gal-Gal
Fúc
Ric
agglutination
no agglutination
agglutination
no agglutination
agglutination
agglutination
no agglutination
no agglutination
R-GlcNAc-Gal-GaNAC
3-2.3-2
R-GNA-Gal-Gal
agglutination
agglutination
agglutination
no agglutination
The Rh antigenic determinants are spaced very far apart on the red cell surface. As
a consequence, IgG antibodies against the Rh antigen do not fix complement and
therefore do not hemolyze red blood cells in vitro. For reasons that are less well
understood, IgG antibodies against the Rh antigen do not agglutinate Rh-positive
red blood cells. Because of this it was very difficult to detect Rh antibodies until
Robin Coombs at the University of Cambridge devised a solution to the prob-
lem by developing antibodies against human immunoglobulin. He showed that
Rh-positive red blood cells coated with IgG anti-Rh antibodies could be taken from
a fetus and agglutinated by antibodies against IgG. Furthermore, he showed that
when the serum of an alloimmunized woman was incubated with Rh-positive red
blood cells, these red blood cells could then be agglutinated by antibody against
IgG (Fig. 44.2). The former is called the direct Coombs test and the latter the indi-
rect Coombs test. This application of immunology to a vexing clinical problem led
ultimately to treatment and prevention of the problem.
The case of Cynthia Waymarsh: a fetus in
immunological distress.
Mrs Waymarsh was 31 years old when she became pregnant for the third time. She
was known to have blood group A, Rh-negative red cells. Her husband was also
type A but Rh-positive. Their first-born child, a male, was healthy. During her second
pregnancy Mrs Waymarsh was noted to have an indirect Coombs titer at a 1:16 dilu-
tion of her serum. The fetus was followed closely, and the delivery of a healthy baby
girl was induced at 36 weeks of gestation.
Five years later, Mrs Waymarsh became pregnant again. At 14 weeks of gestation
her indirect Coombs titer was 1:8, and at 18 weeks it was 1:16. Amniotic fluid was
obtained at 22, 24, 27, and 29 weeks of gestation and was found to have increasing
Transcribed Image Text:248 Case 44: Hemolytic Disease of the Newborn Fig. 44.1 Hemagglutination is used to type blood and match compatible donors and recipients for blood transfusion. Common gut bacteria bear antigens that are similar or identical to blood group antigens, and these stimulate the formation of antibodies against these antigens in individuals who do not bear the corresponding antigen on their own red blood cells (left column); thus, type O individuals, who lack A and B antigens, have both anti-A and anti-B antibodies, whereas type AB individuals have neither. The pattern of agglutination of the red blood cells of a transfusion donor or recipient with anti-A and anti-B antibodies reveals the individual's ABO blood group. Before transfusion, the serum of the recipient is also tested for antibodies that agglutinate the red blood cells of the donor, and vice versa, a procedure called a cross-match, which may detect potentially harmful antibodies against other blood groups that are not part of the ABO system. 30.5 weeks: hematocrit up to 16.3% Further transfusion requested. Serum from individuals of type Anti-A and anti-B antibodies Anti-B antibodies B Anti-A antibodies AB No antibodies against A or B R-GlcNAc-Gal Fue no agglutination no agglutination no agglutination no agglutination Red blood cells from individuals of type Express the carbohydrate structures R-GlcNAc-Gal-GalNAc R-GlcNAc-Gal-Gal Fúc Ric agglutination no agglutination agglutination no agglutination agglutination agglutination no agglutination no agglutination R-GlcNAc-Gal-GaNAC 3-2.3-2 R-GNA-Gal-Gal agglutination agglutination agglutination no agglutination The Rh antigenic determinants are spaced very far apart on the red cell surface. As a consequence, IgG antibodies against the Rh antigen do not fix complement and therefore do not hemolyze red blood cells in vitro. For reasons that are less well understood, IgG antibodies against the Rh antigen do not agglutinate Rh-positive red blood cells. Because of this it was very difficult to detect Rh antibodies until Robin Coombs at the University of Cambridge devised a solution to the prob- lem by developing antibodies against human immunoglobulin. He showed that Rh-positive red blood cells coated with IgG anti-Rh antibodies could be taken from a fetus and agglutinated by antibodies against IgG. Furthermore, he showed that when the serum of an alloimmunized woman was incubated with Rh-positive red blood cells, these red blood cells could then be agglutinated by antibody against IgG (Fig. 44.2). The former is called the direct Coombs test and the latter the indi- rect Coombs test. This application of immunology to a vexing clinical problem led ultimately to treatment and prevention of the problem. The case of Cynthia Waymarsh: a fetus in immunological distress. Mrs Waymarsh was 31 years old when she became pregnant for the third time. She was known to have blood group A, Rh-negative red cells. Her husband was also type A but Rh-positive. Their first-born child, a male, was healthy. During her second pregnancy Mrs Waymarsh was noted to have an indirect Coombs titer at a 1:16 dilu- tion of her serum. The fetus was followed closely, and the delivery of a healthy baby girl was induced at 36 weeks of gestation. Five years later, Mrs Waymarsh became pregnant again. At 14 weeks of gestation her indirect Coombs titer was 1:8, and at 18 weeks it was 1:16. Amniotic fluid was obtained at 22, 24, 27, and 29 weeks of gestation and was found to have increasing
CASE 44
HEMOLYTIC DISEASE
OF THE NEWBORN
The adaptive immune response
distinguishes genetic differences between
individuals of the same species.
Adaptive immune responses evolved to protect vertebrate species against the world
of microorganisms. However, anything discerned as 'nonself' may become a target
of such responses, which can include molecular differences between individuals
within a species. An antigenic determinant present in some members of a species
but not in others is said to show polymorphic variation, and antibodies directed
against such determinants are called alloantibodies. Perhaps the best-known
alloantibodies are those that are used to determine our blood groups. Individuals
who have red cells of type A have alloantibodies that react with the red blood cells
of individuals who are type B and vice versa. Individuals who have red blood cells
of type AB have no alloantibodies, and those with type O red blood cells have anti-
bodies against both A and B red blood cells (Fig. 44.1). These alloantibodies arise
because the capsules of Gram-negative bacteria, which inhabit our gut, bear anti-
gens that stimulate antibodies that cross-react with the carbohydrate antigens of
the ABO blood groups.
Alloantibodies induced by a fetus in the pregnant mother frequently cause serious
problems. Alloimmunization most often results from Rhesus (Rh) incompatibility
between mother and fetus. Approximately 15% of women are Rh-negative; that is,
their red blood cells do not bear the Rh antigen. A woman who is Rh-negative has
an 85% chance of marrying an Rh-positive man, and their chances of having an
Rh-positive baby are very high. Not infrequently, during delivery of the newborn
infant, some blood escapes from the fetal circulation into the maternal circulation,
and as a result of this, the mother develops alloantibodies against the Rh antigen.
During a subsequent pregnancy with an Rh-positive fetus, the maternal IgG alloan-
tibodies cross the placenta and cause destruction of the fetal red cells, causing ane-
mia. As we shall see, the consequences of this can be very serious and result in fetal
death or severe damage to the newborn infant.
TOPICS BEARING
ON THIS CASE:
Antibody
suppression of
B-cell activation
ABO blood groups
Alloantibodies
Rhesus blood group
Coombs test
Hemagglutination
assays
Transcribed Image Text:CASE 44 HEMOLYTIC DISEASE OF THE NEWBORN The adaptive immune response distinguishes genetic differences between individuals of the same species. Adaptive immune responses evolved to protect vertebrate species against the world of microorganisms. However, anything discerned as 'nonself' may become a target of such responses, which can include molecular differences between individuals within a species. An antigenic determinant present in some members of a species but not in others is said to show polymorphic variation, and antibodies directed against such determinants are called alloantibodies. Perhaps the best-known alloantibodies are those that are used to determine our blood groups. Individuals who have red cells of type A have alloantibodies that react with the red blood cells of individuals who are type B and vice versa. Individuals who have red blood cells of type AB have no alloantibodies, and those with type O red blood cells have anti- bodies against both A and B red blood cells (Fig. 44.1). These alloantibodies arise because the capsules of Gram-negative bacteria, which inhabit our gut, bear anti- gens that stimulate antibodies that cross-react with the carbohydrate antigens of the ABO blood groups. Alloantibodies induced by a fetus in the pregnant mother frequently cause serious problems. Alloimmunization most often results from Rhesus (Rh) incompatibility between mother and fetus. Approximately 15% of women are Rh-negative; that is, their red blood cells do not bear the Rh antigen. A woman who is Rh-negative has an 85% chance of marrying an Rh-positive man, and their chances of having an Rh-positive baby are very high. Not infrequently, during delivery of the newborn infant, some blood escapes from the fetal circulation into the maternal circulation, and as a result of this, the mother develops alloantibodies against the Rh antigen. During a subsequent pregnancy with an Rh-positive fetus, the maternal IgG alloan- tibodies cross the placenta and cause destruction of the fetal red cells, causing ane- mia. As we shall see, the consequences of this can be very serious and result in fetal death or severe damage to the newborn infant. TOPICS BEARING ON THIS CASE: Antibody suppression of B-cell activation ABO blood groups Alloantibodies Rhesus blood group Coombs test Hemagglutination assays
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 3 steps

Blurred answer
Knowledge Booster
Immune disorders
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biology and related others by exploring similar questions and additional content below.
Similar questions
Recommended textbooks for you
Human Anatomy & Physiology (11th Edition)
Human Anatomy & Physiology (11th Edition)
Biology
ISBN:
9780134580999
Author:
Elaine N. Marieb, Katja N. Hoehn
Publisher:
PEARSON
Biology 2e
Biology 2e
Biology
ISBN:
9781947172517
Author:
Matthew Douglas, Jung Choi, Mary Ann Clark
Publisher:
OpenStax
Anatomy & Physiology
Anatomy & Physiology
Biology
ISBN:
9781259398629
Author:
McKinley, Michael P., O'loughlin, Valerie Dean, Bidle, Theresa Stouter
Publisher:
Mcgraw Hill Education,
Molecular Biology of the Cell (Sixth Edition)
Molecular Biology of the Cell (Sixth Edition)
Biology
ISBN:
9780815344322
Author:
Bruce Alberts, Alexander D. Johnson, Julian Lewis, David Morgan, Martin Raff, Keith Roberts, Peter Walter
Publisher:
W. W. Norton & Company
Laboratory Manual For Human Anatomy & Physiology
Laboratory Manual For Human Anatomy & Physiology
Biology
ISBN:
9781260159363
Author:
Martin, Terry R., Prentice-craver, Cynthia
Publisher:
McGraw-Hill Publishing Co.
Inquiry Into Life (16th Edition)
Inquiry Into Life (16th Edition)
Biology
ISBN:
9781260231700
Author:
Sylvia S. Mader, Michael Windelspecht
Publisher:
McGraw Hill Education